Confirmation of the Experimentally-Proven Therapeutic Utility of Madecassoside in an Aβ<sub>1-42</sub> Infusion Rat Model of Alzheimer’s Disease by in Silico Analyses

Journals Menu

Follow SCIRP

ISSN Print: 2169-2459
ISSN Online: 2169-2467
www.scirp.org/journal/aad
E-mail: aad@scirp.org

"Confirmation of the Experimentally-Proven Therapeutic Utility of Madecassoside in an Aβ_1-42 Infusion Rat Model of Alzheimer’s Disease by in Silico Analyses"
written by Abdullah Al Mamun, Michio Hashimoto, Shahdat Hossain, Masanori Katakura, Hiroyuki Arai, Osamu Shido,
published by Advances in Alzheimer's Disease, Vol.4 No.2, 2015

has been cited by the following article(s):

[1]	Actions and Therapeutic Potential of Madecassoside and Other Major Constituents of Centella asiatica: A Review
	Applied Sciences, 2021

[2]	PREDICTION OF ACTIVITY SPECTRA OF SUBSTANCES ASSISTED PREDICTION OF BIOLOGICAL ACTIVITY SPECTRA OF POTENTIAL ANTI-ALZHEIMER'S …
	2017

[3]	Prediction of activity spectra of substances assisted prediction of biological activity spectra of potential anti-Alzheimer's phytoconstituents
	2017

[4]	Computational Analyses of Docosahexaenoic Acid (DHA, C22: 6, n-3) with Alzheimer's Disease-Causing Amyloid Peptide Aβ1-42 Reassures Its Therapeutic Utility
	2016

[5]	Computational Analyses of Docosahexaenoic Acid (DHA, C22: 6, n-3) with Alzheimer's Disease-Causing Amyloid Peptide Aβ1-42 Reassures Its Therapeutic …
	2016

[1]	Effect of madecassoside in reducing oxidative stress and blood glucose in streptozotocin–nicotinamide-induced diabetes in rats Journal of Pharmacy and Pharmacology, 2023 DOI:10.1093/jpp/rgad063

[2]	Actions and Therapeutic Potential of Madecassoside and Other Major Constituents of Centella asiatica: A Review Applied Sciences, 2021 DOI:10.3390/app11188475

[3]	Computational Analyses of Docosahexaenoic Acid (DHA, C22:6, n-3) with Alzheimer’s Disease-Causing Amyloid Peptide Aβ_1-42 Reassures Its Therapeutic Utility Advances in Alzheimer's Disease, 2016 DOI:10.4236/aad.2016.52006

Follow SCIRP